A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
You are being asked to take part in a research study of COLD-fX, a product designed to boost
the immune system. COLD-fX is an extract from the roots of North American ginseng and it may
offer some benefit to people with seasonal allergies.
The purpose of the present study is to find out how effective and safe COLD-fX is in
improving quality of life and reducing symptoms of seasonal allergies such as hay fever.
COLD-fX is not yet approved for treatment of seasonal allergies. We are seeking to enroll 200
participants in the Capital Health region.